Back to search results

TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE2

Conditions

Atrial Fibrillation · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Jeannine Ramsey, RN, BSN) · RAMSEYJ8@ccf.org
    Contact: Study coordinator (Yuki Kuramochi, RN, BSN) · kuramoy@ccf.org · 216-445-4063
    Contact: Principal Investigator (Leslie Cho, MD)
    Arwa Younis, MD (Sub-investigator)
    Oussama Wazni, MD (Sub-investigator)
Study leads

  • Leslie Cho, MD

    Principal Investigator

    The Cleveland Clinic

View source on ClinicalTrials.gov(opens in a new tab)